AKYNZEO® Oral Suspension
Chemotherapy-Induced Nausea and Vomiting (CINV)
ApprovedActive
Key Facts
About Helsinn
Helsinn is a third-generation, family-owned, global pharmaceutical company with a 50-year track record, specializing in supportive care and oncology. It leverages a fully integrated business model encompassing development, manufacturing, and commercialization, supported by a state-of-the-art manufacturing facility in Ireland. The company has a direct commercial footprint in the U.S. and partners to reach approximately 90 countries, with a core strategic focus on sustainable growth and ESG principles. Its established portfolio and pipeline are centered on addressing unmet needs in cancer supportive care and rare diseases.
View full company profileTherapeutic Areas
Other Chemotherapy-Induced Nausea and Vomiting (CINV) Drugs
| Drug | Company | Phase |
|---|---|---|
| SUSTOL® | Heron Therapeutics | Approved |
| CINVANTI® | Heron Therapeutics | Approved |